+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Cardiotoxicity - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiotoxicity - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anti-hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2024 - Product Thumbnail Image

No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Pulmonary Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Subarachnoid Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Subarachnoid Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Transient Ischemic Attack - Pipeline Insight, 2024 - Product Thumbnail Image

Transient Ischemic Attack - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Varicose Veins - Pipeline Insight, 2024 - Product Thumbnail Image

Varicose Veins - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Vascular Malformations - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Malformations - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Intracerebral hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Intracerebral hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Arteriovenous fistula (AV) - Pipeline Insight, 2024 - Product Thumbnail Image

Arteriovenous fistula (AV) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Cardiogenic Shock - Pipeline Insight, 2024 - Product Thumbnail Image

Cardiogenic Shock - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Endocarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Endocarditis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Hypertrophic Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Hypertrophic Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Buerger's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 300 Pages
  • Global
From
Atrial Flutter - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Flutter - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more